| Product Code: ETC7552192 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pulmonary embolism market import shipment demonstrated robust growth with a high CAGR from 2020 to 2024. However, there was a slight decline in growth rate between 2023 and 2024. Overall, the market expanded significantly but showed signs of stabilization towards the end of the period.
The India Pulmonary Embolism Market is witnessing significant growth driven by factors such as the increasing prevalence of pulmonary embolism cases, rising awareness about the condition, and advancements in diagnostic techniques and treatment options. The market is characterized by the adoption of novel therapies such as anticoagulant medications, catheter-based interventions, and surgical procedures. Key players in the market are focusing on product innovations, strategic collaborations, and geographical expansions to gain a competitive edge. Government initiatives to improve healthcare infrastructure and access to pulmonary embolism treatments are also contributing to market growth. With a growing geriatric population and lifestyle changes leading to a higher risk of blood clotting disorders, the India Pulmonary Embolism Market is poised for continued expansion in the coming years.
The India Pulmonary Embolism Market is currently experiencing growth opportunities due to the increasing prevalence of risk factors such as obesity, sedentary lifestyle, and smoking. The market is also benefiting from advancements in diagnostic technologies, including computed tomography pulmonary angiography (CTPA) and D-dimer testing, leading to early detection and improved patient outcomes. Additionally, the rising awareness about pulmonary embolism among healthcare professionals and patients is driving the demand for effective treatment options such as anticoagulants and thrombolytics. The market is witnessing a surge in research and development activities focused on developing novel therapies and interventions for pulmonary embolism, presenting lucrative opportunities for pharmaceutical companies and medical device manufacturers to innovate and expand their product portfolios in the Indian market.
In the India Pulmonary Embolism market, several challenges are faced including limited awareness among the general population about the condition, leading to delays in diagnosis and treatment. Additionally, there is a shortage of specialized healthcare professionals with expertise in managing pulmonary embolism, resulting in suboptimal patient care. The high cost of advanced diagnostic tests and treatment options further hinders access to timely and effective care for patients. Furthermore, the lack of comprehensive data collection and reporting systems makes it difficult to accurately track the prevalence and outcomes of pulmonary embolism cases in India, impacting the development of targeted interventions and healthcare policies. Addressing these challenges will require concerted efforts from healthcare providers, policymakers, and industry stakeholders to improve awareness, infrastructure, and access to quality care for pulmonary embolism patients in India.
The India Pulmonary Embolism Market is primarily being driven by factors such as the increasing prevalence of risk factors like obesity, sedentary lifestyle, and smoking, which contribute to the rising cases of pulmonary embolism in the country. Additionally, the growing awareness about the condition among healthcare professionals and patients, coupled with advancements in diagnostic technologies and treatment options, are further fueling the market growth. The Indian government`s initiatives to improve healthcare infrastructure and the availability of affordable treatment options are also playing a significant role in driving the market for pulmonary embolism management in the country. Overall, these factors are expected to continue to propel the growth of the India Pulmonary Embolism Market in the coming years.
The Indian government has implemented various policies to address pulmonary embolism within the healthcare system. These policies focus on improving access to healthcare services, promoting early detection and treatment of pulmonary embolism, and enhancing public awareness about the condition. Additionally, the government has taken steps to regulate the pricing and availability of anticoagulant medications, which are commonly used in the treatment of pulmonary embolism. Furthermore, there is an emphasis on strengthening the infrastructure and capacity of healthcare facilities to better manage pulmonary embolism cases effectively. Overall, these policies aim to reduce the burden of pulmonary embolism in India by ensuring timely and appropriate care for patients while also promoting preventive measures to combat the condition.
The India Pulmonary Embolism Market is expected to witness significant growth in the coming years due to increasing awareness about the condition, advancements in diagnostic technologies, and rising incidences of risk factors such as sedentary lifestyles and obesity. The market is likely to be driven by the growing prevalence of pulmonary embolism cases in India, coupled with improvements in healthcare infrastructure and access to treatments. Additionally, the introduction of novel therapeutics and ongoing research and development activities will further propel market expansion. However, challenges such as limited awareness in rural areas and high treatment costs may hinder market growth to some extent. Overall, the India Pulmonary Embolism Market is anticipated to experience steady growth in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pulmonary Embolism Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pulmonary Embolism Market Revenues & Volume, 2021 & 2031F |
3.3 India Pulmonary Embolism Market - Industry Life Cycle |
3.4 India Pulmonary Embolism Market - Porter's Five Forces |
3.5 India Pulmonary Embolism Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 India Pulmonary Embolism Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 India Pulmonary Embolism Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 India Pulmonary Embolism Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Pulmonary Embolism Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Pulmonary Embolism Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity, smoking, and sedentary lifestyle leading to pulmonary embolism. |
4.2.2 Rising awareness about early diagnosis and treatment options for pulmonary embolism. |
4.2.3 Technological advancements in diagnostic techniques and treatment options for pulmonary embolism. |
4.3 Market Restraints |
4.3.1 Limited availability of advanced healthcare facilities in rural areas of India. |
4.3.2 High cost associated with diagnostic procedures and treatment for pulmonary embolism. |
4.3.3 Lack of skilled healthcare professionals specializing in pulmonary embolism management. |
5 India Pulmonary Embolism Market Trends |
6 India Pulmonary Embolism Market, By Types |
6.1 India Pulmonary Embolism Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 India Pulmonary Embolism Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 India Pulmonary Embolism Market Revenues & Volume, By Shortness of Breath, 2021- 2031F |
6.1.4 India Pulmonary Embolism Market Revenues & Volume, By Chest Pain, 2021- 2031F |
6.1.5 India Pulmonary Embolism Market Revenues & Volume, By Cough, 2021- 2031F |
6.1.6 India Pulmonary Embolism Market Revenues & Volume, By Irregular Heartbeat, 2021- 2031F |
6.1.7 India Pulmonary Embolism Market Revenues & Volume, By Dizziness, 2021- 2031F |
6.1.8 India Pulmonary Embolism Market Revenues & Volume, By Fever, 2021- 2031F |
6.2 India Pulmonary Embolism Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 India Pulmonary Embolism Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.2.3 India Pulmonary Embolism Market Revenues & Volume, By ECG, 2021- 2031F |
6.2.4 India Pulmonary Embolism Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.5 India Pulmonary Embolism Market Revenues & Volume, By CT Scan, 2021- 2031F |
6.2.6 India Pulmonary Embolism Market Revenues & Volume, By Pulmonary Angiography, 2021- 2031F |
6.2.7 India Pulmonary Embolism Market Revenues & Volume, By Venography, 2021- 2031F |
6.2.8 India Pulmonary Embolism Market Revenues & Volume, By D-Dimer Test, 2021- 2031F |
6.2.9 India Pulmonary Embolism Market Revenues & Volume, By D-Dimer Test, 2021- 2031F |
6.3 India Pulmonary Embolism Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 India Pulmonary Embolism Market Revenues & Volume, By Medications, 2021- 2031F |
6.3.3 India Pulmonary Embolism Market Revenues & Volume, By Mechanical Devices, 2021- 2031F |
6.3.4 India Pulmonary Embolism Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 India Pulmonary Embolism Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Pulmonary Embolism Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Pulmonary Embolism Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Pulmonary Embolism Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5 India Pulmonary Embolism Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Pulmonary Embolism Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Pulmonary Embolism Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Pulmonary Embolism Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Pulmonary Embolism Market Import-Export Trade Statistics |
7.1 India Pulmonary Embolism Market Export to Major Countries |
7.2 India Pulmonary Embolism Market Imports from Major Countries |
8 India Pulmonary Embolism Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of pulmonary embolism. |
8.2 Percentage of patients receiving guideline-recommended treatment for pulmonary embolism. |
8.3 Number of hospitals offering specialized care for pulmonary embolism. |
8.4 Patient satisfaction with the quality of care received for pulmonary embolism. |
8.5 Rate of complications and mortality associated with pulmonary embolism treatment. |
9 India Pulmonary Embolism Market - Opportunity Assessment |
9.1 India Pulmonary Embolism Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 India Pulmonary Embolism Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 India Pulmonary Embolism Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 India Pulmonary Embolism Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Pulmonary Embolism Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Pulmonary Embolism Market - Competitive Landscape |
10.1 India Pulmonary Embolism Market Revenue Share, By Companies, 2024 |
10.2 India Pulmonary Embolism Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |